Loading…

Application of the keynote-564 trial results to real life population: which patients with advanced kidney cancer should receive adjuvant pembrolizumab

Saved in:

Bibliographic Details
Published in:	European urology open science (Online) 2022-10, Vol.44, p.S119
Main Authors:	Fallara, G., Rosiello, G., Raggi, D., Marandino, L., Malena, G., Basile, G., Colandrea, G., Cignoli, D., Belladelli, F., Musso, G., Cei, F., Bertini, R., Briganti, A., Salonia, A., Montorsi, F., Larcher, A., Necchi, A., Capitanio, U.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!